Matches in Wikidata for { <http://www.wikidata.org/entity/Q91619662> ?p ?o ?g. }
- Q91619662 description "article scientifique publié en 2019" @default.
- Q91619662 description "artículu científicu espublizáu en xunetu de 2019" @default.
- Q91619662 description "im Juli 2019 veröffentlichter wissenschaftlicher Artikel" @default.
- Q91619662 description "scientific article published on 01 July 2019" @default.
- Q91619662 description "wetenschappelijk artikel" @default.
- Q91619662 description "наукова стаття, опублікована 1 липня 2019" @default.
- Q91619662 description "գիտական հոդված հրատարակված 2019 թվականի հուլիսի 1-ին" @default.
- Q91619662 name "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 name "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 type Item @default.
- Q91619662 label "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 label "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 prefLabel "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 prefLabel "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 P1433 Q91619662-365D813E-51C5-43DB-95B1-9B771DA81515 @default.
- Q91619662 P1476 Q91619662-33EE2843-F208-49AB-BCD3-0420D713D0FE @default.
- Q91619662 P2093 Q91619662-042D19F2-EC9F-4BA8-975F-A71FF0DD1BB1 @default.
- Q91619662 P2093 Q91619662-0EFCF74E-CDD6-4637-B543-442412368D4C @default.
- Q91619662 P2093 Q91619662-1BBE89C1-5745-41F9-BC8E-80C07DE629A5 @default.
- Q91619662 P2093 Q91619662-1C4F77C2-6BB3-4121-BEAD-7A0AF0E41F67 @default.
- Q91619662 P2093 Q91619662-282E2864-31FB-4A3A-9D19-97D780B135BE @default.
- Q91619662 P2093 Q91619662-2DF5CC58-DBD1-41BB-A1CE-0BE1DBA68ACF @default.
- Q91619662 P2093 Q91619662-37ABE603-DB6C-4817-A27A-3BD4C4D49483 @default.
- Q91619662 P2093 Q91619662-5BE89FC7-88EB-4F34-BEF0-5C2D0F8C9380 @default.
- Q91619662 P2093 Q91619662-6391E165-8459-4C9A-B56A-0C6DA2248B68 @default.
- Q91619662 P2093 Q91619662-8FACEA9E-1008-4F88-834A-B1327C880690 @default.
- Q91619662 P2093 Q91619662-A07AF333-337F-4B37-A8F5-08FF4C41643A @default.
- Q91619662 P2093 Q91619662-A145DB64-CFDD-4963-A5ED-4C743A3416C8 @default.
- Q91619662 P2093 Q91619662-AA1E5C0A-550C-4E8B-B49E-A6AAAFF331CE @default.
- Q91619662 P2093 Q91619662-D199096A-0558-47D1-B8DF-260AE3048419 @default.
- Q91619662 P2093 Q91619662-EE7887FB-5633-4E7D-91AE-2980AF9F264B @default.
- Q91619662 P2860 Q91619662-01B916A5-69AC-4D10-A7CC-F51F21734D3A @default.
- Q91619662 P2860 Q91619662-067CEE3A-F52A-463B-A226-5C828767381B @default.
- Q91619662 P2860 Q91619662-21D76FDE-98BC-41D8-9DEE-32DCB734CEC8 @default.
- Q91619662 P2860 Q91619662-286CDF13-55D8-4D1B-96BD-88C2E5A2F538 @default.
- Q91619662 P2860 Q91619662-2CEABA88-A94D-4F2B-AEDF-77A3F8C98C27 @default.
- Q91619662 P2860 Q91619662-30048FB5-E106-43BF-AF4B-10B757020669 @default.
- Q91619662 P2860 Q91619662-553040B6-C8A2-4AA9-9F1E-05E46C27C998 @default.
- Q91619662 P2860 Q91619662-55745986-D5BB-427B-AFBD-2DEE4EA25896 @default.
- Q91619662 P2860 Q91619662-6292DC0D-6AFF-4AC3-9D65-416DC27D0B69 @default.
- Q91619662 P2860 Q91619662-7038BF9E-9791-41AE-A67C-97C2BAB23BCE @default.
- Q91619662 P2860 Q91619662-71656B83-EEA1-4AA9-B791-01D9161C84B2 @default.
- Q91619662 P2860 Q91619662-7FAE29F0-E475-4C31-B247-090840461562 @default.
- Q91619662 P2860 Q91619662-83629D44-96E1-48F5-A35F-6A3EA9D8AA74 @default.
- Q91619662 P2860 Q91619662-843F9999-ECD1-4087-B576-FF27351C27BC @default.
- Q91619662 P2860 Q91619662-86989D92-7E73-457C-8B03-C9925207EE63 @default.
- Q91619662 P2860 Q91619662-87A1CCB6-6BE4-449F-B12F-02912240FD69 @default.
- Q91619662 P2860 Q91619662-8829BDE9-E877-47AA-A80A-D8BCF809F6EA @default.
- Q91619662 P2860 Q91619662-888E43F6-57A0-46F6-A68E-40677E8E4237 @default.
- Q91619662 P2860 Q91619662-89AC01D0-C7E4-4285-9CE5-ED0CFCF9AC40 @default.
- Q91619662 P2860 Q91619662-A44D8DA7-4BBC-418E-88AB-DE576DA2779F @default.
- Q91619662 P2860 Q91619662-A6BFD650-329D-4724-BB40-04414E1CF102 @default.
- Q91619662 P2860 Q91619662-A78790F6-3FB0-4415-B983-93B36245E008 @default.
- Q91619662 P2860 Q91619662-AEB11A23-601F-4D09-A970-2B78F1928C37 @default.
- Q91619662 P2860 Q91619662-B891C537-92B9-49E9-B2DC-EEA0F7A0D4FE @default.
- Q91619662 P2860 Q91619662-BB46C760-B8B9-4DD0-BEE7-7C7262544F15 @default.
- Q91619662 P2860 Q91619662-F2C90A3E-C205-4D96-969D-6A363C6A804B @default.
- Q91619662 P304 Q91619662-68C46E01-AB8D-4DF5-9A96-EF19692252E6 @default.
- Q91619662 P31 Q91619662-66CDC73E-5148-4CE3-9CD6-2D972E43F2D0 @default.
- Q91619662 P356 Q91619662-67527162-B049-485B-ABFA-C394838BD338 @default.
- Q91619662 P433 Q91619662-BD5A4A6C-31DB-4654-A16B-FCE0CF1CF6F8 @default.
- Q91619662 P478 Q91619662-5DBC0549-F8C0-45F4-87C7-A7AD89AD7566 @default.
- Q91619662 P50 Q91619662-1DB74338-5501-44E6-818A-9C5DDD2832C8 @default.
- Q91619662 P50 Q91619662-27A27288-8FDF-469E-AE14-830D9886A4B3 @default.
- Q91619662 P50 Q91619662-5774A743-BAB6-4C61-9093-19EDF90CBB69 @default.
- Q91619662 P50 Q91619662-5E7464D0-E257-45F9-8BED-C0D0E59FFA0F @default.
- Q91619662 P50 Q91619662-652D93A0-51F8-45D8-95D2-E800383CD6E9 @default.
- Q91619662 P50 Q91619662-91885BD5-A99D-459B-9E4A-EB015657AF57 @default.
- Q91619662 P50 Q91619662-9A80638C-2EA8-4AFC-8430-7E36067262DF @default.
- Q91619662 P50 Q91619662-9FCCFB5A-94C7-4DFE-9DD4-5EC8F5EB071F @default.
- Q91619662 P50 Q91619662-A14CF14F-C31F-4D07-A862-EB2AFCB60609 @default.
- Q91619662 P50 Q91619662-C92FD4F8-F79B-430E-931F-C52857999285 @default.
- Q91619662 P577 Q91619662-33021667-815A-4D49-A176-46AA77A4C5DB @default.
- Q91619662 P698 Q91619662-AFA6AB19-A702-4AD0-80E1-79AAA5060606 @default.
- Q91619662 P921 Q91619662-D0F90AC9-B0CD-410E-97D1-D95DF950E74A @default.
- Q91619662 P356 S2213-8587(19)30158-5 @default.
- Q91619662 P698 31272931 @default.
- Q91619662 P1433 Q27725107 @default.
- Q91619662 P1476 "Effects of alirocumab on cardiovascular and metabolic outcomes after acute coronary syndrome in patients with or without diabetes: a prespecified analysis of the ODYSSEY OUTCOMES randomised controlled trial" @default.
- Q91619662 P2093 "Angèle Moryusef" @default.
- Q91619662 P2093 "Arsen D Ristic" @default.
- Q91619662 P2093 "Corinne Hanotin" @default.
- Q91619662 P2093 "Deepak L Bhatt" @default.
- Q91619662 P2093 "Gregory G Schwartz" @default.
- Q91619662 P2093 "Jan Murin" @default.
- Q91619662 P2093 "Kausik K Ray" @default.
- Q91619662 P2093 "Marie Baccara-Dinet" @default.
- Q91619662 P2093 "ODYSSEY OUTCOMES Committees and Investigators" @default.
- Q91619662 P2093 "Rafael Diaz" @default.
- Q91619662 P2093 "Robert A Harrington" @default.
- Q91619662 P2093 "Robert Pordy" @default.
- Q91619662 P2093 "Shaun G Goodman" @default.
- Q91619662 P2093 "Vera A Bittner" @default.
- Q91619662 P2093 "Virginie Loizeau" @default.
- Q91619662 P2860 Q29622947 @default.
- Q91619662 P2860 Q34027392 @default.
- Q91619662 P2860 Q34347054 @default.
- Q91619662 P2860 Q34479098 @default.
- Q91619662 P2860 Q34540403 @default.
- Q91619662 P2860 Q34673134 @default.